These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28192889)

  • 1. Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy.
    Yi JH; Han SW; Kim WY; Kim J; Park MH
    Korean J Intern Med; 2018 Jul; 33(4):763-773. PubMed ID: 28192889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury induced by aristolochic acid in patients with primary glomerular nephritis.
    Tang Z; Chen D; Zhang Y; Chen Z; Chen H; Zeng C; Liu Z
    Ren Fail; 2014 Apr; 36(3):367-71. PubMed ID: 24344833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
    Yang X; Thorngren D; Chen Q; Wang M; Xie X
    Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy.
    Shi M; Ma L; Zhou L; Fu P
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27763560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection.
    Hamano Y; Aoki T; Shirai R; Hatano M; Kimura R; Ogawa M; Yokosuka O; Ueda S
    Nephron Exp Nephrol; 2010; 114(2):e69-81. PubMed ID: 19907192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aristolochic acid induced transdifferentiation and apoptosis in human tubular epithelial cells in vitro].
    Su Z; Xu S; Zheng F; Li Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):301-4. PubMed ID: 12411187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hirsutella sinensis inhibits NLRP3 inflammasome activation to block aristolochic acid-induced renal tubular epithelial cell transdifferentiation.
    Yu M; Man YL; Chen MH; Wu LH; Zhou Y; Zhou XL; Chen N; Ma R; Sun LN
    Hum Cell; 2020 Jan; 33(1):79-87. PubMed ID: 31776855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury.
    Wang Z; Zhao J; Zhang J; Wei J; Zhang J; Huang Y
    Toxicol Lett; 2010 Oct; 198(3):348-57. PubMed ID: 20696222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury.
    Wen YJ; Qu L; Li XM
    Transl Res; 2008 Jul; 152(1):38-46. PubMed ID: 18593636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of aristolochic acid nephropathy in Korea.
    Ban TH; Min JW; Seo C; Kim DR; Lee YH; Chung BH; Jeong KH; Lee JW; Kim BS; Lee SH; Choi BS; Han JS; Yang CW
    Korean J Intern Med; 2018 Sep; 33(5):961-969. PubMed ID: 29551056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological spectrums of aristolochic acid nephropathy.
    Chen D; Tang Z; Luo C; Chen H; Liu Z
    Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome.
    Tsai CS; Chen YC; Chen HH; Cheng CJ; Lin SH
    Am J Med Sci; 2005 Sep; 330(3):153-5. PubMed ID: 16175002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aristolochic acid induces renal tubular injury and inhibits expression of bone morphogenetic protein-7 mRNA in renal tissue of rats].
    Wang HL; Zhang JY
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):501-7. PubMed ID: 18471416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-β1 and Snail Expression.
    Xu XY; Chai JJ; Chen YP; Rui HL; Wang YY; Dong HR; Man YL; Cheng H
    PLoS One; 2016; 11(2):e0149242. PubMed ID: 26890569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.
    Zhou L; Fu P; Huang XR; Liu F; Lai KN; Lan HY
    J Am Soc Nephrol; 2010 Jan; 21(1):31-41. PubMed ID: 19892935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets.
    Declèves AÉ; Jadot I; Colombaro V; Martin B; Voisin V; Nortier J; Caron N
    Exp Physiol; 2016 Jan; 101(1):193-206. PubMed ID: 26442795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats.
    Zhao YY; Zhang L; Mao JR; Cheng XH; Lin RC; Zhang Y; Sun WJ
    J Pharm Pharmacol; 2011 Dec; 63(12):1581-6. PubMed ID: 22060289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice.
    Dai XY; Huang XR; Zhou L; Zhang L; Fu P; Manthey C; Nikolic-Paterson DJ; Lan HY
    Oncotarget; 2016 Mar; 7(10):10841-56. PubMed ID: 26909597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy.
    Sun D; Feng J; Dai C; Sun L; Jin T; Ma J; Wang L
    Am J Nephrol; 2006; 26(4):363-71. PubMed ID: 16873992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.